Founded: 1994
Public Symbol: OCAT
Ocata Therapeutics, Inc. is a biotechnology company applying human embryonic stem cell technology in the emerging field of regenerative medicine. New developments in stem cell biology, and Ocata Therapeutic’s research efforts in particular, have the potential to revolutionize medicine by enabling the production of human cells of any kind for use in a wide-array of therapies for immunological and age-related diseases. The company went public as Advanced Cell Technology via a reverse merger in February, 2005.